UTHEALTH HOME ABOUT SBMI A-Z WEBMAIL INSIDE THE UNIVERSITY |
![]() |
|||||||
|
Fusion Protein:PAPD7-RAF1 |
Fusion Protein Summary |
![]() |
Fusion partner gene information | Fusion gene name: PAPD7-RAF1 | FusionPDB ID: 62587 | FusionGDB2.0 ID: 62587 | Hgene | Tgene | Gene symbol | PAPD7 | RAF1 | Gene ID | 11044 | 6037 |
Gene name | terminal nucleotidyltransferase 4A | ribonuclease A family member 3 | |
Synonyms | LAK-1|LAK1|PAPD7|POLK|POLS|TRF4|TRF4-1|TRF41|TUTASE5 | ECP|RAF1|RNS3 | |
Cytomap | 5p15.31 | 14q11.2 | |
Type of gene | protein-coding | protein-coding | |
Description | terminal nucleotidyltransferase 4ADNA polymerase kappaDNA polymerase sigmaPAP-associated domain-containing protein 7TRAMP-like complex polyadenylate polymerasenon-canonical poly(A) RNA polymerase PAPD7poly(A) RNA polymerase D7, non-canonicalpolymer | eosinophil cationic proteinRNase 3cytotoxic ribonucleaseribonuclease 3ribonuclease, RNase A family, 3 | |
Modification date | 20200313 | 20200313 | |
UniProtAcc | . | P04049 | |
Ensembl transtripts involved in fusion gene | ENST ids | ENST00000230859, | ENST00000251849, ENST00000442415, ENST00000534997, ENST00000542177, |
Fusion gene scores for assessment (based on all fusion genes of FusionGDB 2.0) | * DoF score | 8 X 9 X 7=504 | 19 X 16 X 7=2128 |
# samples | 10 | 18 | |
** MAII score | log2(10/504*10)=-2.33342373372519 possibly effective Gene in Pan-Cancer Fusion Genes (peGinPCFGs). DoF>8 and MAII<0 | log2(18/2128*10)=-3.56342933917152 possibly effective Gene in Pan-Cancer Fusion Genes (peGinPCFGs). DoF>8 and MAII<0 | |
Context (manual curation of fusion genes in FusionPDB) | PubMed: PAPD7 [Title/Abstract] AND RAF1 [Title/Abstract] AND fusion [Title/Abstract] | ||
Most frequent breakpoint (based on all fusion genes of FusionGDB 2.0) | PAPD7(6751310)-RAF1(12641307), # samples:3 | ||
Anticipated loss of major functional domain due to fusion event. | PAPD7-RAF1 seems lost the major protein functional domain in Hgene partner, which is a CGC by not retaining the major functional domain in the partially deleted in-frame ORF. PAPD7-RAF1 seems lost the major protein functional domain in Hgene partner, which is a CGC by not retaining the major functional domain in the partially deleted in-frame ORF. PAPD7-RAF1 seems lost the major protein functional domain in Hgene partner, which is a essential gene by not retaining the major functional domain in the partially deleted in-frame ORF. PAPD7-RAF1 seems lost the major protein functional domain in Hgene partner, which is a essential gene by not retaining the major functional domain in the partially deleted in-frame ORF. |
* DoF score (Degree of Frequency) = # partners X # break points X # cancer types ** MAII score (Major Active Isofusion Index) = log2(# samples/DoF score*10) |
![]() |
Partner | Gene | GO ID | GO term | PubMed ID |
Hgene | PAPD7 | GO:0042493 | response to drug | 10066793 |
Tgene | RAF1 | GO:0002227 | innate immune response in mucosa | 12860195 |
Tgene | RAF1 | GO:0019731 | antibacterial humoral response | 12860195 |
Tgene | RAF1 | GO:0043152 | induction of bacterial agglutination | 23992292 |
Tgene | RAF1 | GO:0045087 | innate immune response | 23992292 |
Tgene | RAF1 | GO:0050829 | defense response to Gram-negative bacterium | 23992292 |
Tgene | RAF1 | GO:0050830 | defense response to Gram-positive bacterium | 12860195|23992292 |
Tgene | RAF1 | GO:0061844 | antimicrobial humoral immune response mediated by antimicrobial peptide | 12860195 |
![]() * Click on the image to open the UCSC genome browser with custom track showing this image in a new window. |
![]() |
![]() * Click on the image to open the UCSC genome browser with custom track showing this image in a new window. |
![]() |
Top |
Fusion Gene Sample Information |
![]() |
![]() * All genome coordinats were lifted-over on hg19. * Click on the break point to see the gene structure around the break point region using the UCSC Genome Browser. |
Source | Disease | Sample | Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand |
ChimerDB4 | PRAD | TCGA-HC-8256-01A | PAPD7 | chr5 | 6751310 | - | RAF1 | chr3 | 12641307 | - |
ChimerDB4 | PRAD | TCGA-HC-8256-01A | PAPD7 | chr5 | 6751310 | + | RAF1 | chr3 | 12641307 | - |
ChimerDB4 | PRAD | TCGA-HC-8256 | PAPD7 | chr5 | 6751310 | + | RAF1 | chr3 | 12641307 | - |
Top |
Fusion ORF Analysis |
![]() |
Henst | Tenst | Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand | Seq length (transcript) | BP loci (transcript) | Predicted start (transcript) | Predicted stop (transcript) | Seq length (amino acids) |
ENST00000230859 | PAPD7 | chr5 | 6751310 | + | ENST00000251849 | RAF1 | chr3 | 12641307 | - | 3268 | 1398 | 129 | 2354 | 741 |
ENST00000230859 | PAPD7 | chr5 | 6751310 | + | ENST00000442415 | RAF1 | chr3 | 12641307 | - | 3071 | 1398 | 129 | 2354 | 741 |
ENST00000230859 | PAPD7 | chr5 | 6751310 | + | ENST00000534997 | RAF1 | chr3 | 12641307 | - | 2602 | 1398 | 129 | 2354 | 741 |
ENST00000230859 | PAPD7 | chr5 | 6751310 | + | ENST00000542177 | RAF1 | chr3 | 12641307 | - | 2536 | 1398 | 129 | 2354 | 741 |
![]() |
Henst | Tenst | Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand | No-coding score | Coding score |
ENST00000230859 | ENST00000251849 | PAPD7 | chr5 | 6751310 | + | RAF1 | chr3 | 12641307 | - | 0.004169403 | 0.9958306 |
ENST00000230859 | ENST00000442415 | PAPD7 | chr5 | 6751310 | + | RAF1 | chr3 | 12641307 | - | 0.006545413 | 0.9934546 |
ENST00000230859 | ENST00000534997 | PAPD7 | chr5 | 6751310 | + | RAF1 | chr3 | 12641307 | - | 0.006169954 | 0.99383 |
ENST00000230859 | ENST00000542177 | PAPD7 | chr5 | 6751310 | + | RAF1 | chr3 | 12641307 | - | 0.006235265 | 0.99376476 |
Top |
Fusion Amino Acid Sequences |
![]() |
>FusionGDB ID_FusionGDB isoform ID_FGname_Hgene_Hchr_Hbp_Henst_Tgene_Tchr_Tbp_Tenst_length(fusion AA) seq_BP >62587_62587_1_PAPD7-RAF1_PAPD7_chr5_6751310_ENST00000230859_RAF1_chr3_12641307_ENST00000251849_length(amino acids)=741AA_BP=422 MSPCPEEAAMRREVVKRIETVVKDLWPTADVQIFGSFSTGLYLPTSDIDLVVFGKWERPPLQLLEQALRKHNVAEPCSIKVLDKATVPII KLTDQETEVKVDISFNMETGVRAAEFIKNYMKKYSLLPYLILVLKQFLLQRDLNEVFTGGISSYSLILMAISFLQLHPRIDARRADENLG MLLVEFFELYGRNFNYLKTGIRIKEGGAYIAKEEIMKAMTSGYRPSMLCIEDPLLPGNDVGRSSYGAMQVKQVFDYAYIVLSHAVSPLAR SYPNRDAESTLGRIIKVTQEVIDYRRWIKEKWGSKAHPSPGMDSRIKIKERIATCNGEQTQNREPESPYGQRLTLSLSSPQLLSSGSSAS SVSSLSGSDVDSDTPPCTTPSVYQFSLQAPAPLMAGLPTALPMPSGKPQPTTSRTLIMTTNNQRPRGQRDSSYYWEIEASEVMLSTRIGS GSFGTVYKGKWHGDVAVKILKVVDPTPEQFQAFRNEVAVLRKTRHVNILLFMGYMTKDNLAIVTQWCEGSSLYKHLHVQETKFQMFQLID IARQTAQGMDYLHAKNIIHRDMKSNNIFLHEGLTVKIGDFGLATVKSRWSGSQQVEQPTGSVLWMAPEVIRMQDNNPFSFQSDVYSYGIV LYELMTGELPYSHINNRDQIIFMVGRGYASPDLSKLYKNCPKAMKRLVADCVKKVKEERPLFPQILSSIELLQHSLPKINRSASEPSLHR -------------------------------------------------------------- >62587_62587_2_PAPD7-RAF1_PAPD7_chr5_6751310_ENST00000230859_RAF1_chr3_12641307_ENST00000442415_length(amino acids)=741AA_BP=422 MSPCPEEAAMRREVVKRIETVVKDLWPTADVQIFGSFSTGLYLPTSDIDLVVFGKWERPPLQLLEQALRKHNVAEPCSIKVLDKATVPII KLTDQETEVKVDISFNMETGVRAAEFIKNYMKKYSLLPYLILVLKQFLLQRDLNEVFTGGISSYSLILMAISFLQLHPRIDARRADENLG MLLVEFFELYGRNFNYLKTGIRIKEGGAYIAKEEIMKAMTSGYRPSMLCIEDPLLPGNDVGRSSYGAMQVKQVFDYAYIVLSHAVSPLAR SYPNRDAESTLGRIIKVTQEVIDYRRWIKEKWGSKAHPSPGMDSRIKIKERIATCNGEQTQNREPESPYGQRLTLSLSSPQLLSSGSSAS SVSSLSGSDVDSDTPPCTTPSVYQFSLQAPAPLMAGLPTALPMPSGKPQPTTSRTLIMTTNNQRPRGQRDSSYYWEIEASEVMLSTRIGS GSFGTVYKGKWHGDVAVKILKVVDPTPEQFQAFRNEVAVLRKTRHVNILLFMGYMTKDNLAIVTQWCEGSSLYKHLHVQETKFQMFQLID IARQTAQGMDYLHAKNIIHRDMKSNNIFLHEGLTVKIGDFGLATVKSRWSGSQQVEQPTGSVLWMAPEVIRMQDNNPFSFQSDVYSYGIV LYELMTGELPYSHINNRDQIIFMVGRGYASPDLSKLYKNCPKAMKRLVADCVKKVKEERPLFPQILSSIELLQHSLPKINRSASEPSLHR -------------------------------------------------------------- >62587_62587_3_PAPD7-RAF1_PAPD7_chr5_6751310_ENST00000230859_RAF1_chr3_12641307_ENST00000534997_length(amino acids)=741AA_BP=422 MSPCPEEAAMRREVVKRIETVVKDLWPTADVQIFGSFSTGLYLPTSDIDLVVFGKWERPPLQLLEQALRKHNVAEPCSIKVLDKATVPII KLTDQETEVKVDISFNMETGVRAAEFIKNYMKKYSLLPYLILVLKQFLLQRDLNEVFTGGISSYSLILMAISFLQLHPRIDARRADENLG MLLVEFFELYGRNFNYLKTGIRIKEGGAYIAKEEIMKAMTSGYRPSMLCIEDPLLPGNDVGRSSYGAMQVKQVFDYAYIVLSHAVSPLAR SYPNRDAESTLGRIIKVTQEVIDYRRWIKEKWGSKAHPSPGMDSRIKIKERIATCNGEQTQNREPESPYGQRLTLSLSSPQLLSSGSSAS SVSSLSGSDVDSDTPPCTTPSVYQFSLQAPAPLMAGLPTALPMPSGKPQPTTSRTLIMTTNNQRPRGQRDSSYYWEIEASEVMLSTRIGS GSFGTVYKGKWHGDVAVKILKVVDPTPEQFQAFRNEVAVLRKTRHVNILLFMGYMTKDNLAIVTQWCEGSSLYKHLHVQETKFQMFQLID IARQTAQGMDYLHAKNIIHRDMKSNNIFLHEGLTVKIGDFGLATVKSRWSGSQQVEQPTGSVLWMAPEVIRMQDNNPFSFQSDVYSYGIV LYELMTGELPYSHINNRDQIIFMVGRGYASPDLSKLYKNCPKAMKRLVADCVKKVKEERPLFPQILSSIELLQHSLPKINRSASEPSLHR -------------------------------------------------------------- >62587_62587_4_PAPD7-RAF1_PAPD7_chr5_6751310_ENST00000230859_RAF1_chr3_12641307_ENST00000542177_length(amino acids)=741AA_BP=422 MSPCPEEAAMRREVVKRIETVVKDLWPTADVQIFGSFSTGLYLPTSDIDLVVFGKWERPPLQLLEQALRKHNVAEPCSIKVLDKATVPII KLTDQETEVKVDISFNMETGVRAAEFIKNYMKKYSLLPYLILVLKQFLLQRDLNEVFTGGISSYSLILMAISFLQLHPRIDARRADENLG MLLVEFFELYGRNFNYLKTGIRIKEGGAYIAKEEIMKAMTSGYRPSMLCIEDPLLPGNDVGRSSYGAMQVKQVFDYAYIVLSHAVSPLAR SYPNRDAESTLGRIIKVTQEVIDYRRWIKEKWGSKAHPSPGMDSRIKIKERIATCNGEQTQNREPESPYGQRLTLSLSSPQLLSSGSSAS SVSSLSGSDVDSDTPPCTTPSVYQFSLQAPAPLMAGLPTALPMPSGKPQPTTSRTLIMTTNNQRPRGQRDSSYYWEIEASEVMLSTRIGS GSFGTVYKGKWHGDVAVKILKVVDPTPEQFQAFRNEVAVLRKTRHVNILLFMGYMTKDNLAIVTQWCEGSSLYKHLHVQETKFQMFQLID IARQTAQGMDYLHAKNIIHRDMKSNNIFLHEGLTVKIGDFGLATVKSRWSGSQQVEQPTGSVLWMAPEVIRMQDNNPFSFQSDVYSYGIV LYELMTGELPYSHINNRDQIIFMVGRGYASPDLSKLYKNCPKAMKRLVADCVKKVKEERPLFPQILSSIELLQHSLPKINRSASEPSLHR -------------------------------------------------------------- |
Top |
Fusion Protein Functional Features |
![]() Go to FGviewer search page for the most frequent breakpoint (https://ccsmweb.uth.edu/FGviewer/chr5:6751310/chr3:12641307) - FGviewer provides the online visualization of the retention search of the protein functional features across DNA, RNA, protein, and pathological levels. - How to search 1. Put your fusion gene symbol. 2. Press the tab key until there will be shown the breakpoint information filled. 4. Go down and press 'Search' tab twice. 4. Go down to have the hyperlink of the search result. 5. Click the hyperlink. 6. See the FGviewer result for your fusion gene. |
![]() |
![]() |
Hgene | Tgene |
. | RAF1 |
FUNCTION: Might normally function as a transcriptional repressor. EWS-fusion-proteins (EFPS) may play a role in the tumorigenic process. They may disturb gene expression by mimicking, or interfering with the normal function of CTD-POLII within the transcription initiation complex. They may also contribute to an aberrant activation of the fusion protein target genes. | FUNCTION: Serine/threonine-protein kinase that acts as a regulatory link between the membrane-associated Ras GTPases and the MAPK/ERK cascade, and this critical regulatory link functions as a switch determining cell fate decisions including proliferation, differentiation, apoptosis, survival and oncogenic transformation. RAF1 activation initiates a mitogen-activated protein kinase (MAPK) cascade that comprises a sequential phosphorylation of the dual-specific MAPK kinases (MAP2K1/MEK1 and MAP2K2/MEK2) and the extracellular signal-regulated kinases (MAPK3/ERK1 and MAPK1/ERK2). The phosphorylated form of RAF1 (on residues Ser-338 and Ser-339, by PAK1) phosphorylates BAD/Bcl2-antagonist of cell death at 'Ser-75'. Phosphorylates adenylyl cyclases: ADCY2, ADCY5 and ADCY6, resulting in their activation. Phosphorylates PPP1R12A resulting in inhibition of the phosphatase activity. Phosphorylates TNNT2/cardiac muscle troponin T. Can promote NF-kB activation and inhibit signal transducers involved in motility (ROCK2), apoptosis (MAP3K5/ASK1 and STK3/MST2), proliferation and angiogenesis (RB1). Can protect cells from apoptosis also by translocating to the mitochondria where it binds BCL2 and displaces BAD/Bcl2-antagonist of cell death. Regulates Rho signaling and migration, and is required for normal wound healing. Plays a role in the oncogenic transformation of epithelial cells via repression of the TJ protein, occludin (OCLN) by inducing the up-regulation of a transcriptional repressor SNAI2/SLUG, which induces down-regulation of OCLN. Restricts caspase activation in response to selected stimuli, notably Fas stimulation, pathogen-mediated macrophage apoptosis, and erythroid differentiation. {ECO:0000269|PubMed:11427728, ECO:0000269|PubMed:11719507, ECO:0000269|PubMed:15385642, ECO:0000269|PubMed:15618521, ECO:0000269|PubMed:15849194, ECO:0000269|PubMed:16892053, ECO:0000269|PubMed:16924233, ECO:0000269|PubMed:9360956}. |
![]() |
- Retained protein feature among the 13 regional features. |
Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Protein feature | Protein feature note |
Hgene | PAPD7 | chr5:6751310 | chr3:12641307 | ENST00000230859 | + | 11 | 13 | 27_79 | 423.0 | 543.0 | Compositional bias | Note=Ala-rich |
Hgene | PAPD7 | chr5:6751310 | chr3:12641307 | ENST00000230859 | + | 11 | 13 | 85_117 | 423.0 | 543.0 | Compositional bias | Note=Ser-rich |
Tgene | RAF1 | chr5:6751310 | chr3:12641307 | ENST00000251849 | 8 | 17 | 349_609 | 330.0 | 649.0 | Domain | Protein kinase | |
Tgene | RAF1 | chr5:6751310 | chr3:12641307 | ENST00000442415 | 9 | 18 | 349_609 | 350.0 | 669.0 | Domain | Protein kinase | |
Tgene | RAF1 | chr5:6751310 | chr3:12641307 | ENST00000251849 | 8 | 17 | 355_363 | 330.0 | 649.0 | Nucleotide binding | ATP | |
Tgene | RAF1 | chr5:6751310 | chr3:12641307 | ENST00000442415 | 9 | 18 | 355_363 | 350.0 | 669.0 | Nucleotide binding | ATP |
- Not-retained protein feature among the 13 regional features. |
Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Protein feature | Protein feature note |
Hgene | PAPD7 | chr5:6751310 | chr3:12641307 | ENST00000230859 | + | 11 | 13 | 576_602 | 423.0 | 543.0 | Compositional bias | Note=Ser-rich |
Hgene | PAPD7 | chr5:6751310 | chr3:12641307 | ENST00000230859 | + | 11 | 13 | 408_468 | 423.0 | 543.0 | Domain | Note=PAP-associated |
Tgene | RAF1 | chr5:6751310 | chr3:12641307 | ENST00000251849 | 8 | 17 | 56_131 | 330.0 | 649.0 | Domain | RBD | |
Tgene | RAF1 | chr5:6751310 | chr3:12641307 | ENST00000442415 | 9 | 18 | 56_131 | 350.0 | 669.0 | Domain | RBD | |
Tgene | RAF1 | chr5:6751310 | chr3:12641307 | ENST00000251849 | 8 | 17 | 138_184 | 330.0 | 649.0 | Zinc finger | Phorbol-ester/DAG-type | |
Tgene | RAF1 | chr5:6751310 | chr3:12641307 | ENST00000442415 | 9 | 18 | 138_184 | 350.0 | 669.0 | Zinc finger | Phorbol-ester/DAG-type |
Top |
Fusion Protein Structures |
![]() * Here we show the 3D structure of the fusion proteins using Mol*. AlphaFold produces a per-residue confidence score (pLDDT) between 0 and 100. Model confidence is shown from the pLDDT values per residue. pLDDT corresponds to the model’s prediction of its score on the local Distance Difference Test. It is a measure of local accuracy (from AlphfaFold website). To color code individual residues, we transformed individual PDB files into CIF format. |
Fusion protein PDB link (fusion AA seq ID in FusionPDB) | Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand | AA seq | Len(AA seq) |
Top |
pLDDT score distribution |
![]() * AlphaFold produces a per-residue confidence score (pLDDT) between 0 and 100. |
RAF1_pLDDT.png![]() |
![]() * AlphaFold produces a per-residue confidence score (pLDDT) between 0 and 100. |
Top |
Ramachandran Plot of Fusion Protein Structure |
![]() |
Fusion AA seq ID in FusionPDB and their Ramachandran plots |
Top |
Fusion Protein-Protein Interaction |
![]() |
![]() |
Gene | PPI interactors |
RAF1 | YWHAQ, YWHAG, YWHAZ, Hras, SFN, HRAS, VDAC1, PEBP4, CNKSR1, RASD2, CNKSR2, ERAS, SPRY4, SPRY2, YWHAB, OIP5, PHKA2, CCT3, MYC, AR, MRAS, KRAS, LRPAP1, RRAS2, SHOC2, TSC22D3, STK26, MAPK1, MAPK3, PRKCE, BCL2, BCL2L1, PEBP1, MAP2K1, GRB10, NRAS, MAPK8IP3, AKT1, HSP90AA1, GNG4, GNB2, VAV1, RHEB, RAP1A, SRC, FYN, RB1, RBL2, PRKG1, JAK2, YWHAH, CFLAR, CDC25A, BRAF, MAP3K1, PDGFRB, MAP3K5, MAPK7, PHB, BAG1, PAK1, PRKCZ, RRAS, PRPF6, UBE2D2, YWHAE, NR3C1, LCK, LTK, JAK1, XIAP, BIRC2, BIRC3, STUB1, Arrb2, EEF1A1, HSP82, HSPA8, HSPA5, CALM1, SGK1, NEDD4, SCNN1B, NEDD4L, STK3, BRAP, WDR83, KSR1, LATS1, MAP2K2, Rfxank, RFXANK, PPP1CC, VCP, HSPD1, BAD, BCL6, BIRC7, PIN1, MMS19, PPP2R1A, PPP2R2B, PPP2CA, HSPA4, RAF1, PPP2CB, MAPK8, RBBP8, YY1, PKM, CDK20, HIPK4, TBXA2R, SH3KBP1, ILK, GPRASP2, CDC37, IRS4, FAM96B, HUWE1, Prkab1, RANBP9, TMEM70, PACSIN3, NPLOC4, PRKAR1A, DCAF8, PURA, FYCO1, MYBPC1, COPS7A, MOV10, NXF1, EGFR, CALU, CCT8, DNAJA1, EMD, TIMM50, LOX, ARRB2, AGTR1, CASZ1, MRC2, PDLIM2, HERC2, XPO1, ACOX1, PCDH7, MAD2L1, SYNPO, TMEM63B, EEF1E1, COPS5, SS18L2, Smn1, Cep152, Aldh4a1, Ksr1, NUP133, RPGRIP1L, NCAPG2, NUP107, MSH2, LAS1L, AMER1, NUP160, EIF3D, SPATA7, NPHP4, DYNLL2, DYNLL1, IQCB1, RMDN3, TRIM25, Mapkbp1, EGLN3, RIPK4, MAPK6, CSNK1A1, HERC1, LZTR1, QKI, COPS3, TRIM28, MAEA, NANOG, ITCH, IRF7, PSMB9, MAP2K5, CDK4, CDK6, CDKN2B, FGFR4, MAP2K3, NF2, PDGFRA, TEAD2, RASSF1, ABCB5, BECN1, CBLC, GLIS2, GRM1, HGF, MAP2K6, ARNT, CCND2, CD44, CDKN2A, CDKN2C, EPHA2, ERBB2, KEAP1, LATS2, MET, NF1, TERT, DUSP2, MBP, PAK2, PLEKHA4, CRBN, ARAF, SLC25A3, TUBB4B, TUBB, HSPA6, HSP90AB3P, HSP90AB1, HSPA1A, HSPB1, BAG2, CCT7, DSG1, CCT2, CCT4, CCT6A, TCP1, AKAP8L, ATAD3A, ABCD3, SLC25A22, TMEM33, TUBA4A, HPX, MGST1, TUBB4A, TMEM161A, HSP90AB2P, CCAR2, SLC25A10, FANCD2, TUBB6, HSD17B12, SLC25A11, SLC25A1, ARL1, DNAJA2, DPM1, CCT5, AIFM1, SQSTM1, TUBG2, TUBG1, STK39, GCN1L1, ABCF2, POLD1, NUBP2, TM9SF3, NCLN, SEC61A2, SEC61A1, ALDH1A3, TUBB3, POLR2B, IARS2, TMED1, CIT, AURKB, KIF20A, BRD1, TRIM66, HAX1, CUL4A, ACTR1A, AKAP1, FLOT1, LAMTOR1, LMAN1, RAB2A, RAB4A, STX7, NPAS1, OPALIN, METTL21B, SSSCA1, FAM174A, CRKL, DDB1, DICER1, LDHB, PIK3R1, NONO, DVL2, |
![]() |
Gene | STRING network |
PAPD7 | |
RAF1 | ![]() |
![]() |
Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Still interaction with |
![]() |
Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Interaction lost with |
Tgene | RAF1 | chr5:6751310 | chr3:12641307 | ENST00000442415 | 9 | 18 | 331_349 | 350.0 | 669.0 | PEBP1/RKIP |
Top |
Related Drugs to PAPD7-RAF1 |
![]() (Manual curation of PubMed, 04-30-2022 + MyCancerGenome) |
Hgene | Tgene | Drug | Source | PMID |
Top |
Related Diseases to PAPD7-RAF1 |
![]() (Manual curation of PubMed, 04-30-2022 + MyCancerGenome) |
Hgene | Tgene | Disease | Source | PMID |
![]() (DisGeNet 4.0) |
Partner | Gene | Disease ID | Disease name | # pubmeds | Source |
Tgene | RAF1 | C0028326 | Noonan Syndrome | 10 | CLINGEN;CTD_human;GENOMICS_ENGLAND;ORPHANET |
Tgene | RAF1 | C0175704 | LEOPARD Syndrome | 7 | CLINGEN;CTD_human;GENOMICS_ENGLAND |
Tgene | RAF1 | C1969057 | Noonan Syndrome 5 | 4 | CTD_human;GENOMICS_ENGLAND;UNIPROT |
Tgene | RAF1 | C1969056 | LEOPARD SYNDROME 2 | 3 | CTD_human;GENOMICS_ENGLAND;UNIPROT |
Tgene | RAF1 | C0007194 | Hypertrophic Cardiomyopathy | 2 | CTD_human |
Tgene | RAF1 | C0041409 | Turner Syndrome, Male | 2 | CTD_human |
Tgene | RAF1 | C1519086 | Pilomyxoid astrocytoma | 2 | ORPHANET |
Tgene | RAF1 | C1527404 | Female Pseudo-Turner Syndrome | 2 | CTD_human |
Tgene | RAF1 | C4551472 | Hypertrophic obstructive cardiomyopathy | 2 | CTD_human |
Tgene | RAF1 | C4551602 | Noonan Syndrome 1 | 2 | CTD_human |
Tgene | RAF1 | C0006142 | Malignant neoplasm of breast | 1 | CTD_human |
Tgene | RAF1 | C0007131 | Non-Small Cell Lung Carcinoma | 1 | CTD_human |
Tgene | RAF1 | C0007193 | Cardiomyopathy, Dilated | 1 | CTD_human |
Tgene | RAF1 | C0017638 | Glioma | 1 | CTD_human |
Tgene | RAF1 | C0020429 | Hyperalgesia | 1 | CTD_human |
Tgene | RAF1 | C0022665 | Kidney Neoplasm | 1 | CTD_human |
Tgene | RAF1 | C0023903 | Liver neoplasms | 1 | CTD_human |
Tgene | RAF1 | C0024121 | Lung Neoplasms | 1 | CTD_human |
Tgene | RAF1 | C0242379 | Malignant neoplasm of lung | 1 | CTD_human |
Tgene | RAF1 | C0259783 | mixed gliomas | 1 | CTD_human |
Tgene | RAF1 | C0340427 | Familial dilated cardiomyopathy | 1 | ORPHANET |
Tgene | RAF1 | C0345904 | Malignant neoplasm of liver | 1 | CTD_human |
Tgene | RAF1 | C0345967 | Malignant mesothelioma | 1 | CTD_human |
Tgene | RAF1 | C0458247 | Allodynia | 1 | CTD_human |
Tgene | RAF1 | C0555198 | Malignant Glioma | 1 | CTD_human |
Tgene | RAF1 | C0587248 | Costello syndrome (disorder) | 1 | CLINGEN |
Tgene | RAF1 | C0678222 | Breast Carcinoma | 1 | CTD_human |
Tgene | RAF1 | C0740457 | Malignant neoplasm of kidney | 1 | CTD_human |
Tgene | RAF1 | C0751211 | Hyperalgesia, Primary | 1 | CTD_human |
Tgene | RAF1 | C0751212 | Hyperalgesia, Secondary | 1 | CTD_human |
Tgene | RAF1 | C0751213 | Tactile Allodynia | 1 | CTD_human |
Tgene | RAF1 | C0751214 | Hyperalgesia, Thermal | 1 | CTD_human |
Tgene | RAF1 | C1257931 | Mammary Neoplasms, Human | 1 | CTD_human |
Tgene | RAF1 | C1275081 | Cardio-facio-cutaneous syndrome | 1 | CLINGEN |
Tgene | RAF1 | C1449563 | Cardiomyopathy, Familial Idiopathic | 1 | CTD_human |
Tgene | RAF1 | C1458155 | Mammary Neoplasms | 1 | CTD_human |
Tgene | RAF1 | C2936719 | Mechanical Allodynia | 1 | CTD_human |
Tgene | RAF1 | C4014656 | CARDIOMYOPATHY, DILATED, 1NN | 1 | CTD_human;UNIPROT |
Tgene | RAF1 | C4551484 | Leopard Syndrome 1 | 1 | CTD_human;GENOMICS_ENGLAND |
Tgene | RAF1 | C4704874 | Mammary Carcinoma, Human | 1 | CTD_human |
Tgene | RAF1 | C4721610 | Carcinoma, Ovarian Epithelial | 1 | CTD_human |